Company profile
Retractable Technologies, Inc.
AMEX: RVP · Healthcare · Medical - Instruments & Supplies
#476 of 1,422 Healthcare companies by revenue62nd-percentile growth
EA Score
57CFH 61DQ 55GM 43SS 69
v0.1 · 65/100 weight · provisional
↑ disclosure history, listing tenure · ↓ 3-yr revenue growth, filing timeliness
Methodology →Revenue TTM
$37.1M
Rev growth YoY (TTM)
+10.1%
Net income (FY)
-$12.6M
Employees
198
as of 2026-08-21
Market cap
$21.9M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$38.3M$38.3M2025
Net income-$12.6M-$12.6M2025
Operating income-$21.2M-$21.2M2025
Total assets$142.6M$142.6M2025
Liabilities$68.3M$68.3M2025
Equity$74.4M$74.4M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Other Products100%
By geography
Not disclosed.
The read
What is Retractable Technologies, Inc.’s revenue?
Retractable Technologies, Inc. booked $38.3M in FY2025 revenue, growing 16% year over year — faster than most Healthcare companies we track, at a -32.8% net margin.
Peers · Healthcare
Interpace Biosciences, Inc.74BPalvella Therapeutics, Inc.54DUtah Medical Products, Inc.80B+Cytosorbents Corporation55CClearPoint Neuro, Inc.62CSunshine Biopharma, Inc.50DNeighbors
Denton →Key facts
CEOThomas J. Shaw
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersLittle Elm, TX
ExchangeAMEX: RVP
Employees198
IPO date2001-05-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.